Robeco Institutional Asset Management B.V. increased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 5.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 151,807 shares of the company's stock after purchasing an additional 7,644 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.09% of Astera Labs worth $54,039,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Astera Labs in the second quarter worth about $6,609,581,000. ABS Investment Management LLC purchased a new position in shares of Astera Labs during the second quarter valued at approximately $1,980,382,000. Van ECK Associates Corp grew its stake in shares of Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock valued at $1,080,980,000 after buying an additional 373,545 shares during the last quarter. Bank of America Corp DE bought a new position in shares of Astera Labs during the second quarter valued at approximately $1,061,791,000. Finally, Atreides Management LP bought a new position in shares of Astera Labs during the second quarter valued at approximately $587,736,000. 60.47% of the stock is currently owned by institutional investors.
Astera Labs Price Performance
Astera Labs stock opened at $257.82 on Friday. The stock has a market cap of $44.73 billion, a price-to-earnings ratio of 187.13 and a beta of 3.68. The firm has a 50-day moving average of $311.83 and a two-hundred day moving average of $303.10. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period last year, the company posted $0.44 earnings per share. The company's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 2.71 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Citigroup downgraded Astera Labs from a "buy" rating to a "hold" rating in a report on Friday, October 9th. Barclays boosted their price objective on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a report on Monday, July 20th. Roth Capital reaffirmed a "buy" rating and issued a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Weiss Ratings raised Astera Labs from a "hold (c)" rating to a "buy (b-)" rating in a research report on Thursday, October 8th. Finally, Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating in a research report on Friday, October 9th. Eleven investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $344.17.
View Our Latest Analysis on Astera Labs
Insider Buying and Selling
In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares of the company's stock, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm's stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the transaction, the director owned 3,309 shares in the company, valued at $909,842.64. The trade was a 73.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 408,558 shares of company stock valued at $127,306,034 over the last 90 days. 10.40% of the stock is owned by insiders.
Astera Labs Company Profile
(
Free Report)
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
See Also
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.